Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825655 · ClinicalTrials.gov registry record · Phase 4
Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT01825655 is a Phase 4 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 3 participants.
The verdict
NCT01825655, a Phase 4 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is determine if long acting antihistamine like cetirizine can help with itching induced by opioid pain medications.
Interventions
- DRUG Cetirizine
- DRUG Placebo or sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01825655
The ClinicalTrials.gov registry entry for NCT01825655 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cetirizine is the first listed.
NCT01825655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01825655 about?
NCT01825655 is a clinical study titled "Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching". The purpose of this study is determine if long acting antihistamine like cetirizine can help with itching induced by opioid pain medications.
What is the current status of trial NCT01825655?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2014-09. Estimated completion is 2017-11.
What interventions are being tested in trial NCT01825655?
The interventions under investigation include: Cetirizine (DRUG), Placebo or sugar pill (DRUG).
Who is sponsoring clinical trial NCT01825655?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.